Optogenetic approaches to vision restoration
- PMID: 30218651
- DOI: 10.1016/j.exer.2018.09.003
Optogenetic approaches to vision restoration
Abstract
Inherited retinal disease (IRD) affects about 1 in 3000 to 1 in 5000 individuals and is now believed to be the most common cause of blindness registration in developed countries. Until recently, the management of such conditions had been exclusively supportive. However, advances in molecular biology and medical engineering have now seen the rise of a variety of approaches to restore vision in patients with IRDs. Optogenetic approaches are primarily aimed at rendering secondary and tertiary neurons of the retina light-sensitive in order to replace degenerate or dysfunctional photoreceptors. Such approaches are attractive because they provide a "causative gene-independent" strategy, which may prove suitable for a variety of patients with IRD. We discuss theoretical and practical considerations in the selection of optogenetic molecules, vectors, surgical approaches and review previous trials of optogenetics for vision restoration. Optogenetic approaches to vision restoration have yielded promising results in pre-clinical trials and a phase I/II clinical trial is currently underway (ClinicalTrials.gov NCT02556736). Despite the significant inroads made in recent years, the ideal optogenetic molecule, vector and surgical approach have yet to be established.
Keywords: Gene therapy; Inherited retinal disease; Optogenetics; Retinitis pigmentosa; Vision restoration.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
[Retinitis pigmentosa: eye sight restoration by optogenetic therapy].Biol Aujourdhui. 2013;207(2):109-21. doi: 10.1051/jbio/2013011. Epub 2013 Oct 10. Biol Aujourdhui. 2013. PMID: 24103341 Review. French.
-
Advances in Ophthalmic Optogenetics: Approaches and Applications.Biomolecules. 2022 Feb 8;12(2):269. doi: 10.3390/biom12020269. Biomolecules. 2022. PMID: 35204770 Free PMC article. Review.
-
[Therapeutic approaches for retinitis pigmentosa].Klin Monbl Augenheilkd. 2013 May;230(5):512-8. doi: 10.1055/s-0032-1328471. Epub 2013 May 21. Klin Monbl Augenheilkd. 2013. PMID: 23695848 Review. German.
-
A light in the dark: state of the art and perspectives in optogenetics and optopharmacology for restoring vision.Future Med Chem. 2019 Mar;11(5):463-487. doi: 10.4155/fmc-2018-0315. Epub 2019 Mar 25. Future Med Chem. 2019. PMID: 30907134 Review.
-
Optogenetic approaches to restoring visual function in retinitis pigmentosa.Curr Opin Neurobiol. 2011 Dec;21(6):942-6. doi: 10.1016/j.conb.2011.06.001. Epub 2011 Jun 25. Curr Opin Neurobiol. 2011. PMID: 21708457 Review.
Cited by
-
Nanoparticle-based optical interfaces for retinal neuromodulation: a review.Front Cell Neurosci. 2024 Mar 20;18:1360870. doi: 10.3389/fncel.2024.1360870. eCollection 2024. Front Cell Neurosci. 2024. PMID: 38572073 Free PMC article. Review.
-
Bioelectronic devices for light-based diagnostics and therapies.Biophys Rev (Melville). 2023 Jan 20;4(1):011304. doi: 10.1063/5.0102811. eCollection 2023 Mar. Biophys Rev (Melville). 2023. PMID: 38505817 Free PMC article. Review.
-
Retinitis Pigmentosa: From Pathomolecular Mechanisms to Therapeutic Strategies.Medicina (Kaunas). 2024 Jan 22;60(1):189. doi: 10.3390/medicina60010189. Medicina (Kaunas). 2024. PMID: 38276069 Free PMC article. Review.
-
Current approaches to vision restoration using optogenetic therapy.Front Cell Neurosci. 2023 Aug 16;17:1236826. doi: 10.3389/fncel.2023.1236826. eCollection 2023. Front Cell Neurosci. 2023. PMID: 37663125 Free PMC article. Review.
-
Current Assistive Devices Usage and Recommendations for a Future Artificial Vision Prosthesis among Patients with Severe Visual Impairment Due to Inherited Retinal Diseases.J Clin Med. 2023 Aug 14;12(16):5283. doi: 10.3390/jcm12165283. J Clin Med. 2023. PMID: 37629325 Free PMC article.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical